JPMorgan Chase & Co. (JPM) : American Economic Planning Group Inc Adv reduced its stake in JPMorgan Chase & Co. by 2.72% during the most recent quarter end. The investment management company now holds a total of 14,669 shares of JPMorgan Chase & Co. which is valued at $969,621 after selling 410 shares in JPMorgan Chase & Co. , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.JPMorgan Chase & Co. makes up approximately 0.38% of American Economic Planning Group Inc Adv’s portfolio.
Other Hedge Funds, Including , Accredited Investors boosted its stake in JPM in the latest quarter, The investment management firm added 671 additional shares and now holds a total of 12,976 shares of JPMorgan Chase & Co. which is valued at $849,409. JPMorgan Chase & Co. makes up approx 0.22% of Accredited Investors’s portfolio.Barrow Hanley Mewhinney Strauss reduced its stake in JPM by selling 896,353 shares or 2.89% in the most recent quarter. The Hedge Fund company now holds 30,137,691 shares of JPM which is valued at $1,972,813,253. JPMorgan Chase & Co. makes up approx 2.90% of Barrow Hanley Mewhinney Strauss’s portfolio.National Investment Services Inc Wi reduced its stake in JPM by selling 1,793 shares or 3.9% in the most recent quarter. The Hedge Fund company now holds 44,213 shares of JPM which is valued at $2,844,222. JPMorgan Chase & Co. makes up approx 3.11% of National Investment Services Inc Wi’s portfolio.Taylor Asset Management Inc boosted its stake in JPM in the latest quarter, The investment management firm added 1,300 additional shares and now holds a total of 9,700 shares of JPMorgan Chase & Co. which is valued at $624,001. JPMorgan Chase & Co. makes up approx 0.17% of Taylor Asset Management Inc’s portfolio.Spc Financial boosted its stake in JPM in the latest quarter, The investment management firm added 600 additional shares and now holds a total of 4,359 shares of JPMorgan Chase & Co. which is valued at $279,150. JPMorgan Chase & Co. makes up approx 0.10% of Spc Financial’s portfolio.
JPMorgan Chase & Co. opened for trading at $65.8 and hit $65.98 on the upside on Wednesday, eventually ending the session at $65.89, with a gain of 0.27% or 0.18 points. The heightened volatility saw the trading volume jump to 1,18,68,065 shares. Company has a market cap of $237,994 M.
On the company’s financial health, JPMorgan Chase & Co. reported $1.55 EPS for the quarter, beating the analyst consensus estimate by $ 0.12 according to the earnings call on Jul 14, 2016. Analyst had a consensus of $1.43. The company had revenue of $24400.00 million for the quarter, compared to analysts expectations of $23843.59 million. The company’s revenue was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.54 EPS.
Many Wall Street Analysts have commented on JPMorgan Chase & Co.. JPMorgan Chase & Co. was Downgraded by Bernstein to ” Mkt Perform” on Aug 16, 2016. JPMorgan Chase & Co. was Downgraded by Citigroup to ” Neutral” on Aug 8, 2016. Berenberg Initiated JPMorgan Chase & Co. on Jul 13, 2016 to “Sell”, Price Target of the shares are set at $52.
JPMorgan Chase & Co. is a financial holding company. The Company is engaged in investment banking financial services for consumers and small businesses commercial banking financial transaction processing and asset management. JPMorgan Chase’s activities are organized into four business segments. The Company’s Consumer & Community Banking segment serves consumers and businesses through personal service at bank branches and through ATMs online mobile and telephone banking. The Corporate & Investment Bank comprising Banking and Markets & Investor Services offers investment banking market-making prime brokerage and treasury and securities products and services. The Commercial Banking (CB) segment delivers industry knowledge local expertise and service to the United States and the United States multinational clients. The Asset Management segment comprises investment and wealth management. The Company also operates a Corporate segment.